Isoniazid hypersensitivity in a child

Tony D Merritt and Peter D Massey
Med J Aust 2009; 190 (7): . || doi: 10.5694/j.1326-5377.2009.tb02464.x
Published online: 6 April 2009

To the Editor: Isoniazid is used extensively for the treatment of active and latent tuberculosis (TB). It is generally well tolerated by children, and hypersensitivity reactions resulting in skin rash and requiring cessation of treatment are rarely reported in this age group.1,2

  • 1 Hunter New England Population Health, Newcastle, NSW.
  • 2 Hunter New England Population Health, Tamworth, NSW.

  • 1. Altet Gómez MN, Alcáide Megías J, Boque Genovard MA. [Toxicity in the current treatment of tuberculosis in children] [Spanish]. An Esp Pediatr 1984; 20: 18-27.
  • 2. Padmini R, Srinivasin S, Nalini P, Mahadevan S. Short course chemotherapy for pulmonary tuberculosis in children. J Trop Pediatr 1993; 39: 361-364.
  • 3. NSW Health. Tuberculosis contact tracing. Policy directive PD2008_017. 7 Apr 2008. (accessed Mar 2009).


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.